Form 4 Filing for Axogen, Inc. - Equity Grant to Director

Amy McBride-Wendell, a director at Axogen, Inc., received an annual equity grant of 4,392 Restricted Stock Units (RSUs) on June 24, 2026. This grant, valued at $185,000 as of the grant date, represents a contingent right to receive one share of Axogen, Inc. common stock per RSU. The RSUs vest on June 24, 2027, marking the one-year anniversary of the grant date. The transaction, reported on Form 4, indicates the acquisition of these units with no cost to the reporting owner, and the shares will be held indirectly.